Basit öğe kaydını göster

dc.contributor.authorUlusoy, N
dc.contributor.authorOtuk, G
dc.contributor.authorGursoy, A
dc.date.accessioned2021-03-03T21:23:09Z
dc.date.available2021-03-03T21:23:09Z
dc.date.issued2001
dc.identifier.citationUlusoy N., Gursoy A., Otuk G., "Synthesis and antimicrobial activity of some 1,2,4-triazole-3-mercapto acetic acid derivatives", FARMACO, cilt.56, sa.12, ss.947-952, 2001
dc.identifier.issn0014-827X
dc.identifier.otherav_5edf83dc-1cb7-44bc-b54c-c3cd88fb7381
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/66307
dc.identifier.urihttps://doi.org/10.1016/s0014-827x(01)01128-4
dc.description.abstractEthyl 5-(2-furyl)-4-ethyl-1,2,4-triazole-3-mercaptoacetate (2), 5-(2-furyl)-4-ethyl-1,2,4-triazole-3-mercaptoacetic acid hydrazide (3) and a series of new N-alkylidene/arylidene-5-(2-furyl)-4-ethyl-1,2,4-triazole-3-mercaptoacetic acid hydrazides (4a-f) were synthesized and evaluated for in vitro antibacterial activity against Staphylococcus aureus ATCC 6538, Staphylococcus epidermidis ATCC 12228, Klebsiella pneumoniae ATCC 4352, Pseudomonas aeruginosa ATCC 1539, Escherichia coli ATCC 8739, Shigella flexneri, Salmonella typhi, Proteus mirabilis and antifungal activity against Candida albicans ATCC 10231 using the disk diffusion and microdilution methods. Compound 0 showed antibacterial activity against some bacteria. The in vitro antimycobacterial activity of the new compounds against Mycobacterium tuberculosis H(37)Rv was evaluated employing the BACTEC 460 radiometric system. The highest inhibition observed was 61% at > 6.25 mug/ml. (C) 2001 Elsevier Science S.A. All rights reserved.
dc.language.isoeng
dc.subjectEczacılık
dc.subjectTemel Bilimler
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.titleSynthesis and antimicrobial activity of some 1,2,4-triazole-3-mercapto acetic acid derivatives
dc.typeMakale
dc.relation.journalFARMACO
dc.contributor.department, ,
dc.identifier.volume56
dc.identifier.issue12
dc.identifier.startpage947
dc.identifier.endpage952
dc.contributor.firstauthorID163715


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster